MI MedCare logo
WhatsAppWhatsApp
Oncology Medical Billing Services for Cancer Treatment & Infusion Practices in the USA header image
99%

Oncology Medical Billing Services for Cancer Treatment & Infusion Practices in the USA

Cancer treatment and infusion billing services for medical oncology practices.

Specialty highlight

99%

Built around payer rules, documentation requirements, and coding nuances.

Infusion Billing Accuracy

99%

Prior Auth Success Rate

97%

Overview

Oncology Billing Services for Chemotherapy Infusion, J-Code & 340B Compliance

Oncology billing is one of the most complex areas in healthcare, involving a combination of intensive E&M services for cancer management and a high volume of intricate infusion and injection services for chemotherapy and supportive care drugs. Our oncology billing service is designed for this complexity. We ensure accurate coding for all office visits, precise billing for chemotherapy and non-chemotherapy infusions, and meticulous management of the 340B program, prior authorizations, and oral oncolytic medications, maximizing your revenue and ensuring compliance.

Chemotherapy Infusion & Administration Coding

Precise administration coding for chemotherapy infusions (96413, 96415, 96417), IV push (96401), and subcutaneous/IM injections (96402, 96405) with correct chemo vs. non-chemo hierarchy and concurrent infusion rules.

Oncology Drug J-Code & Unit Billing

Accurate HCPCS J-code selection and weight-based unit calculation for all oncology drug products, ensuring every dose of chemotherapy, biotherapy, and supportive care medication is captured at the correct billing units.

Prior Authorization & Oncology Drug Management

End-to-end prior authorization for all chemotherapy regimens and high-cost oncology drugs with clinical pathway documentation, step-therapy evidence, and re-authorization management to prevent treatment interruptions.

340B Drug Pricing Program Compliance Billing

Complete 340B covered entity billing support including correct modifier -JG/-TB application, drug tracking documentation, HRSA audit-ready records, and payer-specific 340B reporting requirements.

Challenges

Oncology Billing Challenges That Cost Cancer Practices Revenue

Oncology billing is among the highest-risk and highest-value specialties in medical billing. These are the most common revenue threats our team proactively eliminates for cancer practices.

Key challenges
  • Accurately coding for chemotherapy and non-chemotherapy drug administration (infusion and injection).
  • Managing the complex prior authorization process for expensive oncology drugs.
  • Ensuring proper coding for oral oncolytics and other specialty pharmacy drugs.
  • Navigating the 340B drug pricing program and its reporting requirements.
  • Billing for prolonged infusions and managing hydration and supportive care services.
Our solutions
  • Certified oncology coders with deep expertise in medical oncology, hematology, and infusion services.
  • Precise coding for all levels of E&M services for established and new cancer patients.
  • Expertise in billing for chemotherapy administration (96401-96425) and non-chemotherapy infusions (96360-96379).
  • Meticulous management of drug coding using HCPCS J-codes and units.
  • Proactive prior authorization and re-authorization management for all oncology drugs.
  • Specialized support for 340B program compliance, reporting, and billing.
  • Detailed support for oral oncolytics and buy-and-bill medication management.
Features

How We Protect Oncology Revenue From First Infusion to Final Authorization

Our oncology billing workflow manages the full complexity of cancer care revenue — chemotherapy coding, J-code accuracy, prior authorization, 340B compliance, and oral oncolytic billing.

Chemotherapy Infusion Administration Coding

Precise coding for all chemotherapy infusion modalities (96413, 96415, 96417 for sequential), IV push (96401-96402), and subcutaneous/IM injections (96405-96406) following the correct chemo vs. biotherapy vs. non-chemo hierarchy.

Drug J-Code & Weight-Based Unit Billing

Accurate HCPCS J-code selection and unit calculation for all oncology drugs — including weight-dosed regimens like carboplatin (J9045), paclitaxel (J9265), and pembrolizumab (J9271) — ensuring no under- or over-billing of drug costs.

Supportive Care & Hydration Billing

Expert coding for pre-medication antiemetics, growth factors (G-CSF J0594), bisphosphonates (J2430), and hydration infusions (96360-96361) billed as incidental to or separate from the primary chemotherapy service based on duration rules.

340B Program Compliance & Billing

Complete 340B covered entity billing support including correct modifier -JG and -TB application, comprehensive drug purchase tracking, and HRSA compliance documentation to protect both program eligibility and reimbursement accuracy.

Oral Oncolytic & Specialty Pharmacy Billing

Specialized billing for oral chemotherapy drugs that qualify for medical benefit coverage (J8520, J8521, J8530, J8560, J9999) and coordination with specialty pharmacy under patient assistance programs when coverage gaps exist.

Coding

Oncology Coding Complexities That Impact Chemotherapy Billing & Reimbursement

From infusion sequence hierarchy rules to J-code unit calculation for weight-dosed chemotherapy, these are the precision coding areas that determine oncology revenue accuracy.

Complexity checklist
  • Infusion coding based on the drug (chemotherapy vs. non-chemotherapy) and duration.
  • Correct coding for the drug product using J-codes and the exact number of units administered.
  • Billing for "incidenta" hydration and pre-medications alongside chemotherapy.
  • Coding for injection administration (e.g., 96372) vs. infusion.
Denial triggers

Missing prior authorization for chemotherapy drugs.

Incorrect coding of infusion time or units of drug.

Billing for drugs or supplies included in the administration code.

Lack of medical necessity documentation for specific regimens.

Incorrect J-code for the drug administered.

Codes

Oncology CPT, J-Codes & ICD-10 Codes Used in Cancer Treatment Billing

Our oncology billing team is trained across the complete chemotherapy administration, drug J-code, supportive care, and cancer diagnosis ICD-10 code sets used in medical oncology and hematology practices.

CPT

96413 (Chemo Infusion, 1st hour), 96367 (IV Push, Additional), 99214 (Office Visit), 96401 (Chemo Injection), 96360 (Hydration)

ICD-10

C50.911 (Breast Cancer), C34.90 (Lung Cancer), C18.9 (Colon Cancer), C91.10 (CLL), D46.9 (MDS)

FAQ

Frequently Asked Questions

Got questions? We've got answers

Revenue cycle partners you can trust

Ready to transform your revenue cycle?

Join 500+ healthcare providers who've optimized collections, reduced denials, and gained predictable cash flow with MIMedCare. Get a free consultation and a tailored roadmap for your practice.

  • Dedicated account specialists for every specialty
  • Transparent KPIs with monthly performance reviews
  • HIPAA-ready workflows and secure reporting
Get Free Billing Audit

Newsletter

Get billing insights weekly

Short, practical tips to improve collections and reduce denials.

One email per week. Unsubscribe anytime.

Media Library